Pharma trademark collection with emphasis on: Prescription


Curated Royalty Rate Report
Category: Pharma, Subcategory: Prescription, Created On: 2021-01-27, Record Count: 10



This Trademark collection includes royalty reports related to pharmaceuticals under trademark licenses.
This unique collection of trademark transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Pharma
Subcategory: Prescription
Created On: 2021-01-27
Record Count: 10

Primary Industries

  • Drugs
  • Pharmaceuticals
  • Personal Care Products
  • Disease
  • Pain
  • Therapeutic
  • Hygiene

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 651

License Grant
Licensor hereby grants to the Dutch Licensee an exclusive License to use Licensed Trademarks to manufacture, have manufactured, use, have used, sell, have sold, offer to sell, and import the Product in the Territory for  Normothermic use only and for purposes other than Total Body Washout.
License Property
'Licensed Trademarks' means Hextend,(R) and any other trademark developed or acquired by Licensor for use in connection with the sale of the Product in the Territory.
Field of Use
Product refers to plasma volume expansion, organ preservation, blood replacement, and low temperature surgery.

'Normothermic Use' means use (excluding Total Body Washout) of the Product in surgical or therapeutic procedures in which the patient's body temperature is 12 degrees Centigrade or higher.

Product Formulations
Hydroxyethyl Starch (High

Molecular Weight Hetastarch)                6%

Sodium Chloride                             115 millimoles/liter

Magnesium Chloride Hexahydrate              0.45 millimoles/liter

Calcium Chloride Dihydrate                  2.5 millimoles/liter

Potassium Chloride                          3 millimoles/liter

Glucose                                     5 millimoles/liter

Sodium Lactate                              28 millimoles/liter

IPSCIO Record ID: 256627

License Grant
Licensee shall use the Trademark on any Product.
Japanese Licensor grants an exclusive license, with the right to grant sublicenses, under the Licensed IP Rights to conduct research and to develop, make, have made, use, offer for sale, sell and import Products in the Territory for use in the Field 1, and Field 2.
License Property
Trademark shall mean a trademark defined in the letter agreement for Trademark relating to TM-411.
Field of Use
The technology shall mean the compound known as TM-411, known as Tamibarotene,  and any parts, analogs or derivatives thereof.

The licensed patents refer to manufacturing method for preparing benzoic acid derivatives and Polymorphism.

Field 1 shall mean the pharmaceutical prevention or treatment in humans of the following indications: acute promyelocytic leukemia (APL).

Field 2 shall mean the pharmaceutical prevention or treatment in humans of the following indications: multiple myeloma (MM), myelodysplatic syndrome (MDS), and all solid tumor indications and Field shall collectively mean Field 1 and Field 2.

IPSCIO Record ID: 245916

License Grant
The French Licensor hereby grants to Licensee, and Licensee accepts, an exclusive right and license to identify the Licensed Product by means of the Trademark in the Licensee Territory and to promote, market and sell such Licensed Product in the Licensee Territory under the Trademark.
License Property
Trademark shall mean a trademark owned by Licensor and selected by the Parties for use in connection with a Licensed Product or Improvement in the Licensee Territory pursuant to the Trademark License Agreement.

Trademark is ONECTYL(R)

Field of Use
Licensed Product shall mean a pharmaceutical product containing Compound as its therapeutically active ingredient, formulated in a softgel capsule as per the Specifications, in 20 mg (of Compound expressed as base) and 30 mg (of Compound expressed as base) dosage forms (and any other dosages that may be marketed by Licensor, its Affiliates or sublicensees outside of the Licensee Territory from time to time), suitable for oral use by humans and, with respect to each reference in any Agreement to such defined term that relates only to the Licensee Territory, either (i) is used, offered for sale or sold in the Licensee Territory through the use of all or part of Licensor Know-How or (ii) cannot be manufactured, used, offered for sale or sold in the Licensee Territory without infringing one or more Valid Claims.

Compound shall mean VINORELBINE (INN), a vinca alkaloid derivative.

IPSCIO Record ID: 27159

License Grant
The French Licensor hereby grants to the Licensee an Exclusive License to use the Licensed Trademark as a trademark for the Licensed Product in the U.S.A., its territories and possessions, and Mexico, including the right to grant sublicenses, subject to the terms and conditions of this Agreement.
License Property
Licensed Trademark' shall mean the word '___________' (to be completed later by the parties) or such other word or name as shall be agreed upon by the parties in writing which word or name is to be registered as a trademark in the Territory and owned by Licensor.
Field of Use
'Licensed Product' shall mean any pharmaceutical specialty (whether sold by prescription, over-the-counter, or otherwise) containing the Compound.  

'Compound' shall mean Modafinil and/or other compounds, isomers or salts thereof.

Modafinil compound is the active drug substance contained for use by those suffering from excessive daytime sleepiness associated with narcolepsy.

IPSCIO Record ID: 288913

License Grant
The Japanese Company granted exclusive rights to use said TRADEMARK for the ORAL PRODUCT in the TERRITORY as long as Licensee continues the marketing of the ORAL PRODUCT in the TERRITORY.
License Property
STENDRATM (avanafil)
Field of Use
'FIELD' means treatment of male erectile dysfunction or female sexual dysfunction in humans.

IPSCIO Record ID: 400

License Grant
The Japanese Company has the right to use on an exclusive basis said Trademark for the Oral Product in the Territory as long as Licensee continues the marketing of the Oral Product in the Territory relating to a selective phosphodiesterase type-5 inhibitor compound referred to by a Japanese corporation, as 'T-1790', oral formulation.
License Property
STENDRATM (avanafil)
Field of Use
'FIELD' means treatment of male erectile dysfunction or female sexual dysfunction in humans.

IPSCIO Record ID: 26450

License Grant
Licensor shall grant to the Company an exclusive limited license in the International Territory to use the Abbott Trademark(s), solely for the purpose of promoting distributing and selling the Product in the International Territory.
License Property
The Company has an exclusive limited license to use the Abbott Labs Trademark(s), solely for the purpose of promoting distributing and selling a pharmaceutical product containing the compound 'rubetican'or a derivative thereof as an active ingredient.

Licensor  is a multinational health care with a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products.

IPSCIO Record ID: 223134

License Grant
The French Licensor hereby grants to Licensee an exclusive license, with the right to sublicense to a sub-licensee of rights under the License Agreement, to identify the Licensed Product to be packaged and sold by Licensee under the License Agreement under the Trademarks in the Licensed Territory and to promote, market, sell and use such Licensed Products in the Licensed Territory under the Trademarks during the Term.

Licensor and Licensee shall mutually agree upon one or more trademarks under which Licensee, its Affiliates and sub-licensees will exclusively market the Licensed Products (the 'Trademarks') in the Licensed Territory. Licensor shall own and shall retain the ownership of the entire right, title and interest in and to the Trademarks.

License Property
Licensed Products (the 'Trademarks') shall mean any product containing Milnacipran as an active ingredient, in any formulation and through any mode of administration, that incorporates or uses the Licensed Technology or the manufacture, use or sale of which is within the scope of any claim of the Licensor Patents.

Licensor is a French multinational pharmaceutical and cosmetics company.

Field of Use
Field shall mean FMS and related chronic pain syndromes.  FMS shall mean the prevention and treatment of fibromyalgia syndrome.

IPSCIO Record ID: 203381

License Grant
Licensor grants to Licensee:
– An exclusive license, even as to Licensor, to use the Product Trademarks in connection with the Commercialization of Licensed Products in the Territory; and
– A non-exclusive license to use Designated Licensor Trademarks.
License Property
“Product Trademarks” mean any trademarks, trade dress, logos, slogans, and designs, whether or not registered in the Territory, used to identify or promote any Licensed Product in the Territory,

“Designated Licensor Trademark”

Licensor is a pharmaceutical company focused on transforming medicines that can transform lives.

Field of Use
The Initial Licensed Product means that certain injectable formulation of dihydroergotamine designated as MT 300.  The Field means the treatment of human diseases or conditions by means of a prescription pharmaceutical product.

IPSCIO Record ID: 3839

License Grant
The Licensor granted the Licensee the rights to use the Trademark and Trade Dress, in Brazil.
License Property
The Licensor Trade Dress shall mean the two-dimensional or three-dimensional packaging decorations, designs, slogans, tag lines and appliques that are applied to the Licensed Products or packaging therefor.

Trademark'  shall  mean the mark 'Prevent-X,' any  modification, variation or designation of origin that is confusingly similar thereto.

Field of Use
“Formulation” shall mean the proprietary formulation (including manufacturing technology and processes) comprising Benzalkonium Chloride as an active ingredient with Octoxynol 9 (and others exclusively owned by the Licensor).

“Gel Product” shall mean the spermicide and microbicide contraceptive gel product embodying the Formulation presently being developed by IBC, also known as the GEDA Plus product, designed to prevent the transmission of sexually transmitted diseases including, but not limited to, gonorrhea, chlamydia, syphilis, Trichomonas, herpes I and II and HIV, and which is presently undergoing the appropriate and necessary United States governmental regulatory compliance process to permit Empyrean to include such product as a Licensed Product hereunder.

“Lotion  Products”  (also  known as GEDA  Lotion)  shall mean the hand sanitizing  lotion.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.